Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

5.3%

1 terminated/withdrawn out of 19 trials

Success Rate

92.3%

+5.8% vs industry average

Late-Stage Pipeline

63%

12 trials in Phase 3/4

Results Transparency

58%

7 of 12 completed trials have results

Key Signals

2 recruiting7 with results

Enrollment Performance

Analytics

Phase 4

10(52.6%)

N/A

5(26.3%)

Phase 2

2(10.5%)

Phase 3

2(10.5%)

19Total

Phase 4(10)

N/A(5)

Phase 2(2)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials

NCT06599593Not ApplicableActive Not Recruiting

Leveraging the Seasonal Malaria Chemoprevention Platform to Address Malaria and Malnutrition

Role: collaborator

NCT01668745Phase 4Completed

Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso.

Role: collaborator

NCT01644721Phase 4Completed

Trial of Additional Measles Vaccine to Reduce Child Mortality

Role: collaborator

NCT06599580Not ApplicableRecruiting

Mother Screening for Relapse Using Mid-upper Arm Circumference Among Children Recovered From Severe Acute Malnutrition (Full Scale Trial)

Role: collaborator

NCT06010719Phase 4Recruiting

Azithromycin as Adjunctive Treatment for Uncomplicated Severe Acute Malnutrition

Role: collaborator

NCT05763693Phase 4Not Yet Recruiting

Vitality in Infants Via Azithromycin for Neonates Trial

Role: collaborator

NCT05932992Not ApplicableCompleted

Mother Screening for Relapse Using Mid-upper Arm Circumference Among Children Recovered From Severe Acute Malnutrition

Role: collaborator

NCT04716712Phase 4Active Not Recruiting

Infant Mortality Reduction by the Mass Administration of Azithromycin

Role: collaborator

NCT03676764Phase 4Completed

Community Health Azithromycin Trial in Burkina Faso

Role: collaborator

NCT05284773Not ApplicableWithdrawn

Screening for Acute Malnutrition

Role: collaborator

NCT04657640Phase 3Completed

School-Based Assessment of Micronutrient Interventions in Adolescents in Burkina Faso

Role: collaborator

NCT03676751Phase 4Completed

MORDOR II Burkina Faso: Longitudinal Trial

Role: collaborator

NCT04315272Phase 4Completed

Gut and Azithromycin Mechanisms in Infants and Children II

Role: collaborator

NCT03682653Phase 4Completed

Neonates and Azithromycin, an Innovation in the Treatment of Children in Burkina Faso

Role: collaborator

NCT03187834Phase 4Completed

Antibiotic Resistance and Microbiome in Children Aged 6-59 Months in Nouna, Burkina Faso

Role: collaborator

NCT03568643Phase 3Completed

Azithromycin for Uncomplicated Severe Acute Malnutrition in Burkina Faso (Pilot)

Role: collaborator

NCT02851108Phase 2Completed

Methylene Blue Against Falciparum Malaria in Burkina Faso

Role: collaborator

NCT01409824Not ApplicableUnknown

Health Care Intervention Research- Improving Pre-natal and Maternal Care

Role: collaborator

NCT00261222Phase 2Completed

Efficacy of Amodiaquine in the Treatment of Uncomplicated Falciparum Malaria in Young Children of Burkina Faso

Role: collaborator

All 19 trials loaded